Tenet Healthcare Corp
THC: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| %^# | LOCK|y<%H | LOCK|Rb>Z@# |
Tenet Earnings: Elevated Utilization and Margin Improvement Stoke Momentum
Tenet turned in fourth-quarter results that included 9% revenue, 13% adjusted EBITDA, and 37% adjusted EPS growth to $16.78, materially exceeding previous expectations, including EPS of $15.93-$16.26. Tenet's guidance for 2026 includes continued profit and cash flow growth, too, at the midpoint.
